Introduction {#Sec1}
============

All living cells exhibit an outer surface covered with an array of glycans. These glycans are either loosely attached or covalently linked to surface proteins or lipids. Protein glycosylation is one of the most common posttranslational protein modifications found in all three domains of life (Larkin and Imperiali [@CR35]). In particular, protein *N*-glycosylation is widely distributed in Eukarya and Archaea whereas it is rarely found in Bacteria. In these systems, the biosynthesis of *N*-linked oligosaccharides is initiated by the transfer of a sugar(-1-phosphate) residue from a nucleotide-activated sugar onto the lipid carrier dolichyl phosphate (DolP) or undecaprenyl phosphate (UndP), respectively. The fully assembled lipid-linked glycan is then transferred to a specific Asn (*N*) residue within a target protein.

Eukaryotic protein *N*-glycosylation is initiated by the GlcNAc-1-phosphate transferase Alg7/Dpagt1 (Lehrman [@CR38]; Mclachlan and Krag [@CR44]), which converts UDP-GlcNAc and DolP into UMP and DolPP-GlcNAc. This step is essential in Eukarya and defined mutations in the human Dpagt1 cause severe clinical phenotypes, leading to lethal diseases (Jaeken and Matthijs [@CR31]; Wurde et al. [@CR70]). DolPP-GlcNAc acts as a primer for the elongation of the *N*-glycans by specific glycosyltransferases (GTases), sequentially transferring individual sugars from corresponding nucleotide- or lipid phosphate-activated precursors (Burda and Aebi [@CR12]).

The bacterial protein *N*-glycosylation pathway from *Campylobacter jejuni* starts with the transfer of diacetamido bacillosamine-1-P from UDP-2,4-diacetamido bacillosamine onto the lipid carrier UndP by the phosphotransferase PglC (Glover et al. [@CR23]). Similar to the initiation of protein *N*-glycosylation, the biosynthesis of several other bacterial glycoconjugates starts at the cytoplasmic site of the cell membrane with the formation of an UndPP-linked monosaccharide. Examples include the biosynthesis of O-antigen polymers (Meier-Dieter et al. [@CR45]; Samuel and Reeves [@CR58]; Schmidt et al. [@CR59]), the capsular antigens (Masson and Holbein [@CR42]; Troy et al. [@CR65]; Whitfield [@CR69]), lipopolysaccharide (Alexander and Valvano [@CR1]; Schmidt et al. [@CR59]), teichoic acids (Brown et al. [@CR10]; Ginsberg et al. [@CR22]; Mancuso and Chiu [@CR41]) and the peptidoglycan (Bouhss et al. [@CR8]; Bugg and Brandish [@CR11]; Typas et al. [@CR66]). The initiation step is meditated by different classes of membrane-bound UDP-hex(NAc)-1-phosphate:polyprenyl phosphate sugar-1-phosphotransferase enzymes, which use UndP as an acceptor but differ in their specificity for the nucleotide sugar donor. The bacterial enzyme WecA (formerly known as Rfe) catalyses the first step of biosynthesis of many LPS O-antigens and capsular K-antigens by the transfer of GlcNAc-1-P residue from UDP-GlcNAc onto UndP (Amor and Whitfield [@CR4]).

In Archaea, *N*-glycosylation pathways for three different euryachaea and one crenarchaeon have been described \[for review see (Jarrell et al. [@CR32])\]. In contrast to Eukarya and Bacteria, most of the euryarchaeal *N*-glycans characterised to date, i.e. *Hfx. volcanii*, *Haloarcula marismortui*, *Methanococcus voltae*, and *Pyrococcus furiosus*, are assembled on DolP lipid carrier (Calo et al. [@CR14]; Chang et al. [@CR17]; Guan et al. [@CR25]; Larkin et al. [@CR36]), with two exceptions. *Methanothermus fervidus* assemble their *N*-glycans on DolPP (Hartmann and König [@CR29]) and *Hbt. salinarum*, which synthesizes two distinct *N*-glycans, assembles one on DolP and the second on DolPP (Paul and Wieland [@CR56]). A recent comparison of archaeal lipid-linked oligosaccharides revealed a difference between eury- and crenarchaeota. Indeed, selected species of the euryarchaeota possessed DolP-linked glycans, whereas the crenarchaeota *Pyrobaculum calidifontis* and *Sulfolobus solfataricus* assemble their *N*-glycans on DolPP (Taguchi et al. [@CR64]). Different steps of the *N*-glycosylation pathway of the closely related crenarchaeon *Sulfolobus acidocaldarius* have been studied in detail (Meyer and Albers [@CR46]). Here, a tribranched hexasaccharide, composed of two GlcNAc, two terminal Man, one sulfoquinovose and one terminal Glc are found as the *N*-glycan linked to the S-layer protein (Peyfoon et al. [@CR57]). Interestingly, the basal structure of this archaeal *N*-glycan (GlcNAc~2~Man) resembles this of the eukaryal one and the biosynthesis might rely on homologs to the eukaryal ones.

Unlike in euryarchaeota, the initiation step of the protein *N*-glycosylation process in thermophilic crenarchaeota has not yet been elucidated. In the present study, we identified a candidate enzyme for the initiation step of the protein *N*-glycosylation pathway in *S. acidocaldarius* by homology searches. The identified AglH (Saci0093) is able to restore *N*-glycosylation in a conditional lethal *Saccharomyces cerevisiae alg*7 mutant. Various attempts to delete *aglH* in *S. acidocaldarius* were unsuccessful, and the use of tunicamycin, a specific inhibitor of UDP-HexNAc-1-phosphate:polyprenol phosphate HexNAc-1-phosphotransferases, as well as the treatment with bacitracin interfering with the regeneration of DolP, revealed the essentiality of AglH in *S. acidocaldarius*.

Materials and methods {#Sec2}
=====================

Strains and growth conditions {#Sec3}
-----------------------------

*Sulfolobus acidocaldarius* background strain MW001 (Δ*pyrE*) (Wagner et al. [@CR68]) and the genetically-modified strains *S. acidocaldarius* BM-A120-124 (see Table [1](#Tab1){ref-type="table"}) were grown under shaking conditions in Brock medium at 79 °C, pH 3, and supplemented with 0.1% w/v NZ amine and 0.1% w/v dextrin as carbon and energy source (Brock et al. [@CR9]). For the uracil auxotrophic strains, the growth medium was supplemented with 10 mg ml^−1^ uracil. Gelrite (0.6%) plates were supplemented with the same nutrients, with the addition of 10 mM MgCl~2~ and 3 mM CaCl~2~. For second selection plates, 10 mg ml^−1^ uracil and 100 mg ml^−1^ 5-fluoroorotic acid (5-FOA) were added. Growth of the cultures was monitored by measuring the optical density at 600 nm. The *S. cerevisiae* strains YPH499-HIS-GAL-ALG7 (Mazhari-Tabrizi et al. [@CR43]) used as a control and recipient strain, as well as the complementation strains were grown either in SD medium (2% dextrose, 0.17% Bacto yeast nitrogen base) (repression medium) or in SGR-His medium (4% galactose, 2% raffinose, 0.17% Bacto yeast nitrogen base, 0.5% ammonium sulphate) (non-selective medium). The 1.5% agar plates containing either SGR or SD medium were used for the complementation assay.Table 1Strains used in this studyStrainGenotypeReferencesMW001*S. acidocaldarius* DSM 639 Δ*pyrE*Wagner et al. ([@CR68])BM-A120-124MW001 strain with the integrated plasmid pSVA1229This studyYPH499-HIS-GAL-ALG7Mat *a*; ura3-52; lys2-801^amber^; ade2 ± 101^ochre^ trpl-D63; his3-D200; leu2-D1, GAL-ALG7Mazhari-Tabrizi et al. ([@CR43])

Growth studies with bacitracin and tunicamycin {#Sec4}
----------------------------------------------

Pre-cultures grown to an OD~600~ of 0.4--0.5 were used to inoculate 5 ml of fresh Brock medium (0.1% w/v NZ amine and 0.1% w/v dextrin) to a start OD of 0.01. Directly with inoculation or after reaching exponential growth phase, different concentrations of the antibiotics bacitracin (0.6, 1.2, and 2.4 mM) and tunicamycin (2, 6, 16, and 32 µg/ml) were added. Growth was monitored by measuring the OD~600~ over a time period of 80 h.

Construction of a Δ*aglH* deletion {#Sec5}
----------------------------------

A markerless deletion mutant would represent an important tool to analyse whether the predicted UDP-GlcNAc-1-phosphate:polyprenyl phosphate GlcNAc-1-phosphotransferase (AglH) indeed catalyses the first step of the protein *N*-glycosylation process. A gene deletion plasmid was used for homologous recombination as described previously (Wagner et al. [@CR67]). To construct the deletion plasmid, 800--1000 bp of sequence up- and downstream of *saci0093* was PCR amplified. *Apa*I and *Bam*HI restriction sites were introduced at the 5ʹ ends of the upstream forward primer (1842) and the downstream reverse primer (1845), respectively. The upstream reverse primer (1843) and the downstream forward primer (1844) were each designed to incorporate 15 bp of the reverse complement strand of the other primer, resulting in a 30 bp overlapping stretch. The up- and downstream fragments were fused by overlapping PCR, using the 3ʹ ends of the up- and downstream fragments as primers. The resulting PCR product was cloned into plasmid pSAV407 using the restriction enzymes *Apa*I and *Bam*HI, yielding the plasmid pSVA1229. The plasmid was transformed into *Escherichia coli* DH5α cells, which were subsequently plated on LB agar containing 50 mg ml^−1^ ampicillin. The plasmid was confirmed by sequencing. To avoid restriction in *S. acidocaldarius*, the plasmid was methylated by transformation in *E. coli* ER1821 cells containing pM.EsaBC4I, which expresses a methylase (obtained from NEB).

Cloning of *aglH*~FLAG~ into a *S. cerevisiae expression* vector {#Sec6}
----------------------------------------------------------------

To verify the proposed enzymatic function of AglH we reasoned that *aglH* might be able to complement a conditional lethal yeast *alg*7 mutant, as has previously been demonstrated for the human Alg7 (Eckert et al. [@CR19]) and the AglH of *M. voltae* (Shams-Eldin et al. [@CR60]). We, therefore, cloned *aglH* fused to a FLAG-tag sequence into the pRS426-MET (Mumberg et al. [@CR51]) expression vector. The *aglH* gene was PCR amplified with forward primer (1755) and reverse primer (1756), introducing *Eco*RI and *Xho*I restriction sites, respectively. The 1756 primer incorporated the FLAG-tag sequence upstream of the *Xho*I restriction site. The digested PCR fragment was cloned into the expression vector pRS426-MET (Mumberg et al. [@CR51]) linearised with the restriction enzymes *Eco*RI and *Xho*I, creating plasmid pSAV1212 (Table [3](#Tab3){ref-type="table"}). The plasmid was transformed into *E. coli* DH5α, and was confirmed by sequencing.

Oligonucleotide-directed mutagenesis of *aglH*~FLAG~ {#Sec7}
----------------------------------------------------

Plasmid pSVA1212 was used as a template for the oligonucleotide-directed mutagenesis of *aglH* ~FLAG~. In general, a PCR with a specific forward and reverse primers (Table [2](#Tab2){ref-type="table"}) carrying the nucleotide exchange were used to amplify the gene. The resulting PCR products were digested with *Dpn*I to exclude the methylated template plasmid pSVA1229. After purification, each construct was transformed into *E. coli* DH5α, and platted on selective LB plates containing 50 mg ml^−1^ ampicillin. The exchange of the nucleotides was confirmed by sequencing of the entire *aglH* ~FLAG~ gene.Table 2Oligonucleotide primers used in this studyPrimer numberPrimer sequence (5′--3′)Restriction site/amino acid exchangeΔ*aglH*1842CCCACT[GGGCCC]{.ul}GAGAGTGTTAGAAAGAGAAGA*Apa*I1843GGTTATCGTAACCGTCAGGGATACGAGCATTATTTTCTCCTTCTT1844ATGCTCGTATCCCTGACGGTTACGATAACCATCTAATGATATACA1845CGCCGA[GGATCC]{.ul}TCAACGTGGAATTCCCTCTCC*Bam*HI*aglH* ~FLAG~1755GCGG[GAATTC]{.ul}ATGCTCGTATCCCTGCTTGGTATTC*Eco*RI1756GGCG[CTCGAG]{.ul}TTACTTGTCATCGTCCTTGTAGTCAATGATGGTTATCGTAACCGT TTG*Xho*I-FLAG*aglH* ~FLAG~ point mutation2740GGTTTTACAGGGAAGG[CT]{.ul}ATAAATAAATTGACTAAGD039A2741CATCATCCTTAGTCAATTTATTTAT[AG]{.ul}CCTTCCCD039A2742CTTGGTCTACTTGATG[CT]{.ul}ATTTTCAACATAAGCCAGD100A2743GTTGAAAAT[AG]{.ul}CATCAAGTAGACCAAGAAAACCD100A2758GGGAAGGACATAAAT[GC]{.ul}ATTGACTAAGGATGATGTTCCK042A2759CCTTAGTCAAT[GC]{.ul}ATTTATGTCCTTCCCTGTAAAACCK042A2760CTTGATGACATTTTC[GC]{.ul}CATAAGCCAGGCTACTAGN103A2761CCTGGCTTATG[GC]{.ul}GAAAATGTCATCAAGTAGACCN103A2764CTATCCGGCT[GC]{.ul}AACTTTTCCAGGAAATATAGGTACK218A2765TATTTCCTGGAAAAGTT[GC]{.ul}AGCCGGATAGAAATTGK218A2766CAATTTCTATCCGGCTAAAACT[GC]{.ul}TCCAGGAAATATAGGF220A2767AATAAAATAAGTACCTATATTTCCTGGA[GC]{.ul}AGTTTTAGCCGGF264A2768GATCGTCAATTTTTCCGAACGAGACTCCCTTA[GC]{.ul}CCTAGTTTTAGF264A*aglH* ~FLAG~Yeast4125AATCA[CTGCAG]{.ul}ATGCTCGTATCCCTGCTTGG*Pst*I4126GGC[GGAATTC]{.ul}TTACTTGTCATCGTCGTCCTTGTAGTCAATGATGGTTATCGTAACCGTTTG*Eco*RI-FLAGMutated nucleotides and restriction sites are *underlined*

Transformation and selection of *S. acidocaldarius* mutants {#Sec8}
-----------------------------------------------------------

Competent cells were obtained according to the protocol of Kurosawa and Grogan (Kurosawa and Grogan [@CR34]). Aliquots containing 400--600 ng of methylated plasmids (pSVA1229 or pSVA1246) were mixed with 50 µl of competent MW001 cells and incubated for 5 min on ice. Electroporation was performed using a Gene pulser II (Bio-Rad, USA) with the input parameters 1.25 kV, 25 mF, 1000 W in 1 mm cuvettes. Immediately after the pulse, 50 µl of a 2 × concentrated recovery solution (1% sucrose, 20 mM β-alanine, 20 mM malate buffer pH 4.5, 10 mM MgSO~4~) was added and the samples were incubated for 30 min at 75 °C under mild shaking conditions (150 rpm). Prior to plating, additionally 100 µl of heated 2x-concentrated recovery solution was added, and 2 × 100 µl was spread on gelrite plates containing Brock medium supplemented with 0.1% NZ-amine and 0.1% dextrin, lacking uracil. After incubation for 5--7 days at 75 °C, large brownish colonies were used to inoculate 50 ml of first selection Brock medium containing 0.1% NZ-amine. After 3 days of incubation at 75 °C, each culture was screened for the presence of the integrated plasmid by PCR. Positively tested isolates were inoculated in Brock medium (0.1% NZ-amine and 0.1% dextrin) and grown until an OD~600~ of 0.4 was reached. 40 µl of aliquots were then spread on second selection plates, where the recombination step was selected by the presence of 5-fluoroorotic acid (5-FOA) and uracil. After incubation for 5--7 days at 75 °C, differently sized colonies were picked and streaked onto new second selection plates to ensure single colony formation. Colonies were screened by PCR for the presence or the deletion of *saci0093* (*aglH)*, using the outer primers (1842 and 1845).

Transformation and selection of the deletion mutant in YPH 499 *alg*7::HIS3/GAL1-*alg*7 {#Sec9}
---------------------------------------------------------------------------------------

The YPH 499 strain (Mat a; *ura*3--52; *lys*2--801^amber^; *ade*2--101^ochre^; *trp*1-∆63; *his*3-∆200; *leu*2-∆1) (Sikorski and Hieter [@CR61]) has been used to replace the native *alg7* promoter with a selection marker/promoter HIS3/GAL1 cassette, resulting in strain YPH 499 *alg*7::HIS3/GAL1-*alg*7 (Mazhari-Tabrizi et al. [@CR43]). The introduction of the HIS3/GAL1 cassette eliminated the strain's auxotrophy for histidine and placed the *alg7* gene under the regulation of GAL1. YPH499 was transformed with the plasmid pSVA1212, as described previously (Eckert et al. [@CR19]) and inoculated on SD medium plates, lacking uracil and histidine.

Immunostaining of the AglH~FLAG~ point mutations expressed in *S. cerevisiae* {#Sec10}
-----------------------------------------------------------------------------

Cell pellets of the same OD~600~ from 5 ml of SGR medium cultures of YPH499-HIS-GAL-ALG7 transformed with the AglH complementation plasmids (Table [3](#Tab3){ref-type="table"}) were resuspended in 1 ml of buffer A (100 mM NaCl, 100 mM Tris--HCl, 1 mM EDTA, pH 8) and lysed by 20 min sonification with an intensity of 60% and an interval 20 s (Bandelin Sonopuls). Unbroken cells were removed by centrifugation at 3000×*g* at 4 °C for 20 min. The supernatant was centrifuged in a Beckman Coulter Optima Max-XP Ultracentrifuge at 120,000×*g* at 4 °C for 45 min to obtain the membrane pellet. The membrane pellet was resuspended in 0.5 ml of buffer A. Aliquots of 30 µl were loaded on an 11% SDS-PAGE and run at 100 V. The expression of AglH~FLAG~ was analysed by Western immune blotting using the primary antibody anti-DYKDDDDK (Carl Roth, Germany) and an anti-rabbit IgG--alkaline phosphatase-coupled antibody (Sigma Aldrich, St Louis, USA). Chemifluorescence was measured in a Fujifilm LAS-4000 Luminescent image analyzer (Fujifilm, Duesseldorf, Germany).Table 3Plasmids used in this studyPlasmidGenotypeReferencespUC18Cloning vector; Amp^r^Yanisch-Perron et al. ([@CR74])pSAV407Gene targeting plasmid, pGEM-T Easy backbone, *pyr*EF cassette of *S. solfataricus*Wagner et al. ([@CR68])pSVA1229Δ*aglH* cloned into pSVA407This studypSVA1246*aglH* ~STREP~ cloned into pSVA407This studypRS426 METGene targeting and expression vectorMumberg et al. ([@CR51])pSVA1212*aglH* ~FLAG~ (Saci0093) cloned into pRS 426 MET with *Xho*I, *Eco*RIThis studypSVA1247Based on pSVA1212 containing *aglH*-~**D039A-**~FLAGThis studypSVA1248Based on pSVA1212 containing *aglH*-~**D100A**~-FLAGThis studypSVA1258Based on pSVA1212 containing *aglH*-~N103A~-FLAGThis studypSVA1259Based on pSVA1212 containing *aglH*-~K218A~-FLAGThis studypSVA1260Based on pSVA1212 containing *aglH* ~Δ218-329~This studypSVA1261Based on pSVA1212 containing *aglH*-~K042A~-FLAGThis studypSVA1262Based on pSVA1212 containing *aglH*-~F264A~-FLAGThis studypSVA1263Based on pSVA1212 containing *aglH*-~F220A~-FLAGThis studypUC18\_*aglH* ~FLAG~Base on pUC18 containing *aglH* from *S. acidocaldarius*This study

Results {#Sec11}
=======

Identification of AglH, a predicted UDP-GlcNAc-1-phosphate:dolichyl phosphate GlcNAc-1-phosphotransferase {#Sec12}
---------------------------------------------------------------------------------------------------------

To identify the enzyme required for the first step of the protein *N*-glycosylation pathway in the thermoacidophilic crenarchaeon *S. acidocaldarius,* its genome was analysed for the presence of eukaryotic, bacterial, and archaeal homologues of the UDP-GlcNAc-1-phosphate:dolichyl phosphate GlcNAc-1-phosphotransferase Alg7/Dpagt1, WecA, and AglH, respectively. This search identified *saci0093* (*SACI_RS00435*) encoding a predicted UDP-GlcNAc-1-phosphate:dolichyl phosphate GlcNAc-1-phosphotransferase, which shares 27% amino acid sequence identity with the yeast Alg7 and the human Dpagt1, 31% with AglH from the euryarchaeon *M. voltae* and 26% with WecA of *E.coli*. *Saci0093* is located in a gene locus downstream of genes whose products are predicted to be involved in the early steps of isoprenoid lipid biosynthesis (Fig. [1](#Fig1){ref-type="fig"}). The gene s*aci0091* (*SACI_RS00425*, *idi*) codes for an isopentenyl diphosphate delta-isomerase, which is necessary for the biosynthesis of isoprenoid compounds via the mevalonate pathway (Boucher et al. [@CR7]). The corresponding protein from *S. shibatae* is an isopentenyl-diphosphate delta-isomerase that catalyses the interconversion between two active units for isoprenoid biosynthesis, isopentenyl diphosphate (IPP) and dimethylallyl diphosphate (DMAPP) (Nakatani et al. [@CR52]; Yamashita et al. [@CR73]). *Saci0092* (*SACI_RS00430*, *gds*) encodes a bifunctional geranylgeranyl pyrophosphate synthase that synthesizes both farnesyl pyrophosphate (FPP) and geranylgeranyl pyrophosphate (GGPP) (Ohnuma et al. [@CR54]; Ohnuma et al. [@CR53]). GGPP is an intermediate for the biosynthesis of many isoprenoid compounds like carotenoids, geranylgeranylated proteins, as well as archaeal ether-linked membrane lipids. Furthermore, GGPP acts as a precursor in the proposed DolP biosynthesis pathway (Guan et al. [@CR26]). Analyses of the *Sulfolobales* transcriptome revealed a polycistronic mRNA of s*aci0092* and s*aci0093* (Wurtzel et al. [@CR71]), indicating a coordinated gene regulation and/or expression for the biosynthesis of DolP and the DolPP-GlcNAc primer in the *N*-glycosylation process.Fig. 1Physical map of the gene region adjacent to *algH* of *S. acidocaldarius*. Illustrated are the genes *Saci0088* until *Saci0096*. The gene *aglH* displayed in*black* (*saci0093, SACI_RS00435*) encodes the UDP-GlcNAc-1-phosphate:dolichyl phosphate GlcNAc-1-phosphotransferase. The genes *idi* (*saci0091*) and *gds* (*saci0092*) are involved in the isoprenoid lipids biosynthesis

AglH from *S. acidocaldarius* shows high similarity in primary sequence and transmembrane topology with eukaryal and bacterial UDP-GlcNAc-1-phosphate:polyprenyl phosphate GlcNAc-1-phosphotransferases {#Sec13}
-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Topology prediction of AglH (Saci0093) in combination with the known primary sequence revealed high levels of similarities with eukaryal as well as bacterial GlcNAc-1-phosphotransferases. AglH possesses ten transmembrane (TM) helices separated by five internal and four external hydrophilic loops (Fig. [2](#Fig2){ref-type="fig"}). A similar topology was shown for the eukaryal Alg7 enzyme with ten predicted TM domains, while bacterial WecA typically exhibits ten to eleven TM domains (Anderson et al. [@CR5]; Lehrer et al. [@CR37]). For the archaeal homologue from *M. voltae* only seven TM domains have been predicted (Shams-Eldin et al. [@CR60]). An alignment of AglH with the eukaryal, bacterial, and archaeal orthologues illustrated high amino acid similarity within each of the five cytoplasmic loops, indicating a possibly conserved function across the three domains of life (Fig. [3](#Fig3){ref-type="fig"}).Fig. 2Topology model of AglH from *S. acidocaldarius*. The topological model was derived using the TMHMM server (<http://www.cbs.dtu.dk/services/TMHMM/>) and PSIPRED protein structure prediction server (<http://bioinf.cs.ucl.ac.uk/psipred/>). Conserved amino acids (see alignment Fig. [3](#Fig3){ref-type="fig"}) are shown in *bold*. *Numbers* indicate internal cytoplasmic loops I to V, as well as their conserved motifs. Proposed catalytic interaction with UDP-GlcNAc is displayed in *light grey*. *Boxed* amino acids were replaced by alanine Fig. 3Alignment of archaeal, bacterial, and eukaryal UDP-GlcNAc-1-P transferase orthologs. Orthologs were identified using BLAST with *S. acidocaldarius* Saci0093 (AglH). Protein sequences were aligned with the ClustalW program. The partial alignment is shown for the region encompassing the conserved motifs DxxK (CL I), DDxxN/D (CL II) and NxxNxxxxGxxGxxxxG (CL III). Conserved amino acids are indicated with asterisks. The boundaries of transmembrane domains (*filled boxes*) and cytosolic loops (*lines*) are shown on *top* of the alignment. The replacement of selected amino acids from AglH of *S. acidocaldarius* by alanine (**a**) are indicated above the sequence

In the cytoplasmic loop (CL) I, a conserved D~39~xxK/N motif is detected (Figs. [2](#Fig2){ref-type="fig"}, [3](#Fig3){ref-type="fig"}). In the CL II of Saci0093, a D~99~D~100~xxN~103~ motif is present, similar to the conserved motif of eukaryal and bacterial DDxxD motifs (Fig. [3](#Fig3){ref-type="fig"}). This conserved motif is potentially involved in Mg^2+^ cofactor binding (Amer and Valvano [@CR3]; Lloyd et al. [@CR39]; Xu et al. [@CR72]). Within the fifth TMD, the CL III, and the six TMD, a long N~158~xxN~161~xxxxG~165~xxG~168~xxxxG~173~ motif is present. The two conserved aspartic residues have been mutated in the *E. coli* WecA~DD156/159GG~, which resulted in only 3% of the wt transferase activity (Amer and Valvano [@CR3]). The impaired function in vivo and the reduction of enzyme activity in vitro suggest the importance of this motif for the catalytic activity. This motif, in combination with the DDxxK/N motif of the second cytoplasmic loop, resembles the characteristics of a Walker B motif (Amer and Valvano [@CR3]). The large predicted CL V is thought to be involved in the recognition of the carbohydrate moiety of the UDP-GlcNAc donor. In the respective loop of bacterial WecA, a conserved histidine residue is located within a less conserved short-sequence motif HIHH (Amer and Valvano [@CR2]; Anderson et al. [@CR5]). Replacement of the highly conserved His~279~ residue with serine rendered WecA unable to restore O7 production in an *E. coli wec*A::Tn10 strain (Lehrer et al. [@CR37]). Unlike bacteria, eukaryal and archaeal orthologues are missing the HIHH motif. If the functional interpretation for WecA is correct, this raises the question of how the carbohydrate moiety of the UDP-GlcNAc donor is being recognized in these two domains of life (Fig. [3](#Fig3){ref-type="fig"}).

Collectively, the sequence features for AglH are entirely consistent with it being a UDP-GlcNAc-1-phosphate:polyprenyl phosphate GlcNAc-1-phosphotransferase participating in the *N*-glycosylation pathway.

AglH is essential for viability in *S. acidocaldarius* {#Sec14}
------------------------------------------------------

Based on the obvious conservation of the different motifs within the cytoplasmic loops as well as the characteristic topology profile of AglH (Saci0093), we propose that *algH* indeed encodes a UPD-GlcNAc-1-P transferase initiating the protein *N*-glycosylation process by transferring GlcNAc-1-P from UDP-GlcNAc to DolP. To verify his hypothesis, we designed the plasmid pSVA1229, incorporating the up- and downstream region enclosing Δ*aglH*, to create a markerless deletion mutant of *aglH* in *S. acidocaldarius* by homologues recombination. Integration of this plasmid in *S. acidocaldarius* MW001 was confirmed by PCR using primers encompassing the flanking regions of the target gene. A second homologous recombination, enforced by the addition of 5-fluoroorotic acid, resulted in the segregation of the plasmid, generating either the wild-type stain or the preferred Δ*aglH* deletion strain. Screening of more than 150 different colonies by PCR using primers derived from the flanking regions revealed only the presence of wild-type genetic organization. This result suggests that AglH and *N*-glycosylation process is essential for the archaeon. Polar effects cannot be completely excluded; however, they are unlikely, given the fact that the integration of the plasmid could be achieved and this did not alter the archaeal phenotype. Furthermore, all essential genes for isoprenoid lipid biosynthesis are located upstream of the *aglH*. The segregation of the plasmid would not disturb the genetic neighbourhood, as the integrants did not show any evident alteration in growth.

To underline the essentiality of AglH activity, we explored the growth of *S. acidocaldarius* in the presence of antibiotics interfering specifically with the initiation of the *N*-glycosylation. Tunicamycin, a nucleoside antibiotic, resembles UDP-HexNAc residue and specifically inhibits UDP-HexNAc:polyprenol-P HexNAc-1-P transferases by blocking the active site (Esko and Bertozzi [@CR21]). Bacitracin interferes with the dephosphorylation of isoprenyl pyrophosphate hindering the recycling of new isoprenyl phosphate lipid carrier (Stone and Strominger [@CR63]). The addition of both antibiotics, after reaching early exponential growth phase, showed a dose-dependent reduction of growth of *S. acidocaldarius* (Fig. [4](#Fig4){ref-type="fig"}a, b). The addition of 0.3 mM bacitracin (*t* ~d~ = 10.7 ± 0.6 h) did not significantly reduce the growth compared to the wt doubling time (*t* ~d~ = 9.2 ± 0.9 h), whereas the addition of 1.2 and 2.4 mM bacitracin decreased the growth two- and fourfold (*t* ~d~ = 18.5 ± 2.5 h; *t* ~d~ = 42.1 ± 4 h), respectively. In addition, the addition of tunicamycin reduced the growth rate of *S. acidocaldarius*. Here, 2 µg/ml (*t* ~d~ = 13.6 h ± 1.6) and 6 µg/ml (*t* ~d~ = 16.4 h ± 1.2) led to a significant reduction of growth. Furthermore, the addition of 16 µg/ml increased the doubling time to 40.1 h ± 1.3 for the next 20 h. No growth was detected after 20 h in the samples treated with 16 µg/ml tunicamycin and with the two highest bacitracin concentrations. Interestingly, cells appeared larger compared to wt strain. Thus, the increased OD within the first hours may be attributed to an enlarged cell size. At 32 µg/ml no growth could be detected (Fig. [4](#Fig4){ref-type="fig"}b). The effect of the antibiotics inhibiting *N*-glycosylation and thereby inhibiting cell growth was the most obvious when the antibiotics were directly added after inoculation (Fig. [4](#Fig4){ref-type="fig"}c). Here, first the OD~600~ slightly increased to 0.1--0.15, then no growth could be detected over 70 h. Based on the reduced stability of the antibiotics (i.e. tunicamycin) at the growth condition (pH 3, 75 °C), the cells recover growth after 70 h.Fig. 4Effect on the cell growth of *S. acidocaldarius* by the *N*-glycosylation inhibiting antibiotics bacitracin and tunicamycin. **a** Different concentrations of bacitracin: 0 mM (*filled circle*), 0.6 mM (*filled triangle*), 1.2 mM (*filled diamond*), 2.4 mM (*filled square*) mM were added after reaching exponential phase, indicated by *black arrow*. **b** Different concentrations of tunicamycin: 0 (*filled circle*), 2 µg/ml (*filled triangle*), 6 µg/ml (*filled diamond*), 16 µg/ml (*filled square*), 32 µg/ml (*open square*) were added after reaching exponential phase. **c** Cell growth without antibiotics (*filled circle*), with 1.2 mM bacitracin (*filled square*), or 6 µg/ml tunicamycin (*filled triangle*), antibiotics were added directly after inoculation of the culture, indicated by *black arrow*

AglH restores growth of a conditional lethal *alg*7 yeast mutant in a complementation assay {#Sec15}
-------------------------------------------------------------------------------------------

To confirm the function of AglH, we tested whether this gene is able to complement a conditional lethal yeast *alg7* mutant, as has been successfully shown for the human *alg*7 (Eckert et al. [@CR19]) and *aglH* of *M. voltae* (Shams-Eldin et al. [@CR60]). The full length *algH* gene was cloned into a yeast shuttle vector pRS426Met (Mumberg et al. [@CR51]), containing the selective marker *ura3* ^+^, resulting in the plasmid pSVA1212. After transformation of this plasmid into the conditional lethal yeast *alg*7 mutant, YPH499-HIS-GAL-ALG7 (Mazhari-Tabrizi et al. [@CR43]), transformants were plated on SGR as well as SD medium lacking histidine and uracil. Using plates containing either SGR medium (containing galactose) or SD medium (lacking galactose), in which the endogenous yeast *alg*7 is expressed or repressed, respectively. Cells transformed with the empty pRS426Met vector served as a negative control and displayed growth only on galactose-containing plates, i.e. conditions under which endogenous *alg*7 was expressed (Fig. [5](#Fig5){ref-type="fig"}). Under *alg*7 repression conditions, this strain failed to grow. Strains containing the plasmid carrying the human *alg*7 (positive control) (Eckert et al. [@CR19]) or the *aglH* gene displayed sustained growth on glucose-containing plates, demonstrating the ability of the gene product to functionally replace the essential function of the yeast Alg7 enzyme (Fig. [5](#Fig5){ref-type="fig"}). These results showed that *S. acidocaldarius* AglH is indeed functional in *S. cerevisiae* and able to suppress the lethal phenotype of *alg*7 by catalysing the transfer of GlcNAc-1-P onto DolP.Fig. 5Rescue of a conditional lethal *alg*7 yeast mutant by the thermophilic *aglH* from *S. acidocaldarius.* YPH499-HIS-GALprom-ALG7 was transformed with the pRS426-METt plasmids carrying either the human ALG7 (*Hs*-*alg*7) or the archaeal Saci0093 (*Saci*-*aglH*). Transformed cells were streaked onto plates containing minimal medium lacking histidine and uracil and containing either galactose or glucose

Replacement of conserved amino acids resulted in a functional loss of AglH {#Sec16}
--------------------------------------------------------------------------

The complementation assay was employed to verify the functional importance of distinct conserved amino acid residues in the predicted cytoplasmic loops (CL) of *Saci*AglH. The residues mutated were D~39~ and K~42~ in CL I, D~100~ and N~103~ in CL II, K~218~ and F~220~in CL IV and F~264~ in CL V; all were replaced individually by alanine. Mutations were introduced in the plasmid containing the *aglH* (Saci0093) gene fused to sequences encoding a FLAG epitope tag. The AglH-FLAG fusion protein is fully functional and allows growth of the conditional lethal yeast mutants on SD medium (Fig. [6](#Fig6){ref-type="fig"}). Mutations in CL I (D~039~A and K~042~A) had no effect on the function of the AglHFLAG protein. Also N~103~A and K~218~A mutations in CL II and CL III did not affect growth of the yeast mutant. In contrast, the strain complemented with the D~100~A showed no growth under conditions that repressed the yeast *alg*7 gene, implying that D~100~ could be essential for catalysis. The F~220~A and F~264~A mutations in CL IV and CL V, respectively, had different effects. While the F~220~A mutant was substantially impaired in activity as indicated by very poor growth in the complementation assay (Fig. [6](#Fig6){ref-type="fig"}), the F~264~A mutant appeared inactive. To investigate the function of the C-terminal part of the enzyme, a stop codon was introduced at amino acid position 218 AglH~Δ218-329~.The insertion of a stop codon prevented the ability to functionally complement the Alg7 phenotype. These results showed that the amino acids D~100~, F~220~ and F~264~ in AglH are important for successful complementation of the lethal phenotype of YPH499-HIS-GAL-ALG7.Fig. 6Functional characterization of AglH in YPH499-HIS-GAL-ALG7 by a complementation assay. The conditional lethal mutant YPH499-HIS-GAL-ALG7 was transformed with the pRS426-METt plasmid carrying either the archaeal *aglH* (Saci0093) or *aglH* with selected point mutations, resulting in the exchange of conserved amino acids to alanine. The transformed cells were then streaked onto plates containing minimal medium lacking histidine as well as uracil and containing either galactose (**a**) or glucose (**b**). The exchange of the conserved amino acids D~100~A, F~264~A resulted in a lethal, whereas the exchange of F~220~A resulted in a slow-growing phenotype of YPH499-HIS-GAL, under repression condition of the *alg*7 gene (**b**)

Exchange of conserved amino acid residues did not change the expression level of AglH~FLAG~ {#Sec17}
-------------------------------------------------------------------------------------------

To ensure that the AglH~FLAG~ derivatives were expressed and to eliminate the possibility of reduced protein stability due to the amino acid replacements, protein expression was investigated. The membrane fraction of each of the mutated AglH~FLAG~ transformed strains was examined by immuno blotting (Fig. [7](#Fig7){ref-type="fig"}). AglH was detected in the wild-type and all mutated AglH~FLAG~ versions, showing that the lack of function observed in Fig. [7](#Fig7){ref-type="fig"} for the D~100~A, F~220~A, and F~264~A mutations is not caused by reduced protein expression or degraded protein. The observed molecular weight of AglH~FLAG~ corresponds to the calculated molecular weight of 36.6 kDa.Fig. 7Detection of the protein expression from the derived AglH~FLAG~ point mutation by Western immunoblotting. Equivalent amounts of cells from YPH499 background strain (*lane 1*) or the complemented strains with the AglH~FLAG~ expression vector (*lane 2--9*) were separated by 11% SDS-PAGE and immunoblotted with antibodies raised against the FLAG-tag epitope. The non-mutated AglH~FLAG~ (n. m.) showed a similar expression level as the different AglH~FLAG~ point mutations (*lane 3--9*)

Discussion {#Sec18}
==========

Over the last decade, research on archaeal *N*-glycosylation pathways has revealed the diversity of the glycosylation process in terms of the involvement of specific GTases, as well as the structural and compositional complexity of archaeal *N*-glycans (Jarrell et al. [@CR32]). In addition, these studies demonstrated a significant role of glycosylation for the stability of S-layer proteins as well as for the stability and the assembly of the archaellum, the archaeal motility structure (Calo et al. [@CR13]; Yurist-Doutsch et al. [@CR75]). In the thermoacidophilic crenarchaeon family *Sulfolobales*, most if not all surface-exposed proteins (Palmieri et al. [@CR55]), including the S-layer protein (Meyer et al. [@CR49]), the archaellin (Meyer et al. [@CR50]; Meyer et al. [@CR49]), and sugar binding proteins (Elferink et al. [@CR20]), are post-translationally modified by *N*-glycosylation. Defects in *N*-glycan biosynthesis resulted in a significant effect of the growth under elevated salt concentrations as well as a reduced motility (Meyer et al. [@CR49], [@CR50]).

To understand the *N*-glycosylation in *S. acidocaldarius* in more detail, we searched for the enzyme initiating this process. We identified *aglH* (*saci0093*), coding for a UDP-GlcNAc-1-phosphate:dolichyl phosphate GlcNAc-1-phosphotransferase, which shows high similarities in the overall topology as well as in the amino acid sequence with the eukaryotic Alg7, bacterial WecA, and archaeal homologs (Fig. [3](#Fig3){ref-type="fig"}). Based on these structural and sequence similarities, we analysed whether AglH acts also as a functional homolog by complementation of a conditional *alg7* yeast deletion mutant. Such complementation has been successfully demonstrated previously with the euryarchaeal AglH (Mv1751) from *M. voltae* (Shams-Eldin et al. [@CR60]). Here, we showed that also the thermophilic AglH enzyme complements defects in the biosynthesis of pyrophosphate-linked GlcNAc-isoprenoid units of Eukarya. Although the AglH from *S. acidocladarius* is adapted to high temperatures of around 75 °C, this enzyme is still able to complement the conditional lethal *alg*7 yeast mutant restoring the *N*-glycosylation process at 28 °C.

In addition to the ability of AglH to function in Eukarya, we could demonstrate that the substitution of conserved amino acid residues D~100~, F~220~, and F~264~ leads to loss of function in the in vivo complementation assay in yeast (Fig. [6](#Fig6){ref-type="fig"}). The inability of the AglH D~100~A mutant to complementing the conditional yeast mutant is consistent with the substitution of the two aspartic acids DD~90/91~GG in WecA of *E. coli,* where the mutant was impaired in its activity in vitro and in an in vivo complementation system (Amer and Valvano [@CR3]). It is proposed that the DDxxN/D motif and the conserved motif (NxxNxxxGxxGLxxG) of CL III catalyse the formation of the diphosphate linkage of DolPP-GlcNAc (Fig. [3](#Fig3){ref-type="fig"}), as the two conserved motifs show sequence similarity to the Walker B motif (Amer and Valvano [@CR3]). The substitution of the highly conserved F~220~ located in the CL IV leads to a drastic reduction in the ability of the AglH to functionally replace Alg7 in yeast. Although little growth could be detected on glucose-containing plates (non-permissive), which is most likely in response to a small amount of Alg7 remaining from the pre-culture on SRG medium, a significantly reduced activity of the AglH F~220~A is obvious. The data for this mutant align well with the corresponding F~249~L in eukaryotic UDP-GlcNAc:dolichol-P GlcNAc-1-P transferase (GTP), which resulted in a loss of more than half of the enzymatic activity (Dal Nogare et al. [@CR18]). The function of the less conserved F~264~, is unclear, but the whole CL V might be involved in the in recognizing the nucleotide-activated sugar donor. Apart from proposed function of the CL V, the overall basic loop might be involved in the oligomerization or interaction with cytosolic GTases. Recently, Alg13/Alg14, which catalyses the second step in eukaryotic *N*-glycan biosynthesis, was found to interact with Alg7. This interaction tethers the soluble Alg13/Alg14 GTases to the membrane of the ER (Lu et al. [@CR40]), which allows the enhanced biosynthesis of the *N*-glycan by clustering the GTase reactions. As *S. acidocaldarius* possesses also a chitobiose core as the *N*-linking unit at the reducing terminus of its *N*-glycan like Eukarya (Peyfoon et al. [@CR57]; Zahringer et al. [@CR76]), a comparable assembly process might also be present in this archaeon. However, bioinformatics searches for an Alg13/Alg14 ortholog in *S. acidocaldarius* failed to identify an *N*-acetylglucosamine transferase.

Deletion of *aglH* was not possible, implicating an essential role of this gene for the viability of *S. acidocaldarius*. This result is consistent with the inability to delete the key enzyme AglB of the *N*-glycosylation process, catalysing the transfer of the oligosaccharide onto target proteins (Meyer and Albers [@CR47]). Treatment with antibiotics directly interfering with the function of AglH function furthermore strengthened the importance of AglH for cell survival (Fig. [4](#Fig4){ref-type="fig"}). Studies of the membrane-bound pyrophosphatase SepP (Saci1025) in *S. acidocaldarius,* recycling DolPP back into DolP precursor, revealed the necessity of this DolP cycle (Meyer and Schafer [@CR48]). Here, supplementation of bacitracin interfering with the function of SepP into the growth medium led to the death of the cells, consistent with our findings (Fig. [4](#Fig4){ref-type="fig"}). Also treatment with tunicamycin has been previously shown to result in a reduced growth, a gradual increase in cell size, and cell death in *S. acidocaldarius* (Hjort and Bernander [@CR30]). Furthermore, treatment of tunicamycin resulted also in a reduction in the relative amount of glycosylated proteins (Grogan [@CR24]), underlining that this process is indeed important for generating *N*-glycans. However, at that time, no analyses on the lipid-linked glycans confirming the presence of DolPP-linked glycans in *S. acidocaldarius* or other crenarchaeota have been performed. Analyses of the lipid-linked glycans in euryarchaea revealed the presents of DolP rather than DolPP-linked oligosaccharide (Chaban et al. [@CR16]; Guan et al. [@CR25]; Taguchi et al. [@CR64]). In *Hfx. volcanii* and in *M. voltae*, the enzymes AglK and AglJ have been shown to initiate the *N*-glycosylation process by creating DolP-linked glycans, respectively (Kaminski et al. [@CR33]; Chaban et al. [@CR16]; Larkin et al. [@CR36]). Interestingly, besides AglK, a homolog of AglH/Alg7/Dpagt1 has been identified in *M. voltae* (Chaban et al. [@CR15]). A complementation assay in yeast, as it was done in this study, revealed that this AglH is able to replace the function of the eukaryal Alg7, which transfers GlcNAc-1-P from UDP-GlcNAc to DolP, yielding DolPP-GlcNAc (Shams-Eldin et al. [@CR60]). Therefore, it was previously proposed that AglH initiates the *N*-glycosylation in *M. voltae*. However, lipid analyses as well as a detailed biochemical characterisation of AglK and AglH revealed that DolPP-GlcNAc in *M. voltae* is not used for the *N*-glycan assembly, as only DolP-linked oligosaccharides have been detected (Larkin et al. [@CR36]). The study furthermore showed that AglK and AglC, the second enzyme of the *N*-glycosylation pathway, synthesize DolP-GlcNAc-Glc-2,3-diNAcA. This DolP-linked disaccharide is transferred by AglB onto a target peptide in vitro, proving that DolP not only can act as an acceptor but also is used as the glycan donor in *M. voltae* (Larkin et al. [@CR36]).

Here, we proposed that in contrast to euryarchaea the *N*-glycan in crenarchaeon *Sulfolobus* is assembled on DolPP, similar to Eukarya. In fact, two recent studies confirmed the presence of the DolPP-linked *N*-glycans in *Sulfolobales* (Guan et al. [@CR27]; Taguchi et al. [@CR64]). Interestingly the study of Taguchi et al. underlined the difference of the lipid carrier between cren- and euryarchaea, as in all analysed euryarchaea DolP-linked oligosaccharides were present, whereas in the crenarchaea *P. calidifontis* and *S. solfataricus* lipid-linked oligosaccharides were assembled on DolPP backbone (Taguchi et al. [@CR64]). The use of DolPP like in Eukarya emphasises the close evolutionary relationship between Crenachaeota and Eukarya and strengthens the proposed origin of Eukarya from within the TACK super phylum, comprising also the crenarchaeota (Archibald [@CR6]; Guy and Ettema [@CR28]). Interestingly, a newly characterised archaeal phylum, termed Lokiarchaeota, proposed to be one of the deepest branched archaea forms a monophyletic group with eukaryotes in phylogenomic analyses. Within the genomes of these Lokiarchaeota subunits of the eukaryal oligosaccharyltransferase complex are found, i.e. OST3/OST6 (Spang et al. [@CR62]), which had not been found in Archaea so far. This indicates that the archaeon, from which the eukaryotic cell emerged, might have possessed an already highly developed protein *N*-glycosylation pathway.

With this study, we have identified the enzyme that catalyses the first step of the protein *N*-glycosylation process in *S. acidocaldarius*. This will facilitate a more detailed understanding of the archaeal version of this posttranslational modification. Future analyses will be directed to identify additional components of the thermophilic crenarchaeal protein *N*-glycosylation process.
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